vs
Side-by-side financial comparison of Massimo Group (MAMO) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $21.0M, roughly 1.3× Massimo Group). Massimo Group runs the higher net margin — 9.5% vs -147.1%, a 156.6% gap on every dollar of revenue. On growth, Massimo Group posted the faster year-over-year revenue change (15.7% vs -67.6%).
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
MAMO vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.0M | $28.1M |
| Net Profit | $2.0M | $-41.3M |
| Gross Margin | 41.5% | — |
| Operating Margin | 13.1% | -147.6% |
| Net Margin | 9.5% | -147.1% |
| Revenue YoY | 15.7% | -67.6% |
| Net Profit YoY | 215.0% | -182.8% |
| EPS (diluted) | $0.05 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0M | $28.1M | ||
| Q3 25 | $17.0M | $32.5M | ||
| Q2 25 | $18.9M | $15.7M | ||
| Q1 25 | $14.9M | $8.0M | ||
| Q4 24 | $18.2M | $86.6M | ||
| Q3 24 | $25.6M | $2.1M | ||
| Q2 24 | $35.4M | $500.0K | ||
| Q1 24 | $30.2M | $0 |
| Q4 25 | $2.0M | $-41.3M | ||
| Q3 25 | $1.5M | $-51.2M | ||
| Q2 25 | $77.7K | $-44.9M | ||
| Q1 25 | $-2.1M | $-33.9M | ||
| Q4 24 | $-1.7M | $49.9M | ||
| Q3 24 | $-2.5M | $-19.1M | ||
| Q2 24 | $2.8M | $-12.5M | ||
| Q1 24 | $3.2M | $-10.3M |
| Q4 25 | 41.5% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 13.1% | -147.6% | ||
| Q3 25 | 10.5% | -163.7% | ||
| Q2 25 | 0.8% | -302.9% | ||
| Q1 25 | -18.2% | -466.3% | ||
| Q4 24 | -15.4% | 54.5% | ||
| Q3 24 | 1.2% | -1051.6% | ||
| Q2 24 | 10.1% | -3068.0% | ||
| Q1 24 | 13.2% | — |
| Q4 25 | 9.5% | -147.1% | ||
| Q3 25 | 9.0% | -157.4% | ||
| Q2 25 | 0.4% | -285.6% | ||
| Q1 25 | -14.0% | -425.7% | ||
| Q4 24 | -9.5% | 57.7% | ||
| Q3 24 | -9.8% | -925.0% | ||
| Q2 24 | 8.0% | -2503.2% | ||
| Q1 24 | 10.6% | — |
| Q4 25 | $0.05 | $-0.41 | ||
| Q3 25 | $0.04 | $-0.52 | ||
| Q2 25 | $0.00 | $-0.46 | ||
| Q1 25 | $-0.05 | $-0.35 | ||
| Q4 24 | $-0.05 | $0.52 | ||
| Q3 24 | $-0.06 | $-0.20 | ||
| Q2 24 | $0.07 | $-0.13 | ||
| Q1 24 | $0.08 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.8M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $23.7M | $114.3M |
| Total Assets | $51.4M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $245.0M | ||
| Q3 25 | $2.6M | $288.2M | ||
| Q2 25 | — | $240.1M | ||
| Q1 25 | $3.0M | $275.7M | ||
| Q4 24 | $10.2M | $314.0M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $218.7M | ||
| Q1 24 | — | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $23.7M | $114.3M | ||
| Q3 25 | $21.7M | $147.7M | ||
| Q2 25 | $20.2M | $192.3M | ||
| Q1 25 | $19.9M | $229.0M | ||
| Q4 24 | $21.7M | $256.8M | ||
| Q3 24 | $22.5M | $201.0M | ||
| Q2 24 | $24.7M | $215.2M | ||
| Q1 24 | $18.1M | $223.9M |
| Q4 25 | $51.4M | $327.7M | ||
| Q3 25 | $44.4M | $372.8M | ||
| Q2 25 | $45.9M | $313.5M | ||
| Q1 25 | $46.4M | $327.3M | ||
| Q4 24 | $54.9M | $351.2M | ||
| Q3 24 | $57.1M | $217.6M | ||
| Q2 24 | $49.9M | $222.0M | ||
| Q1 24 | $47.3M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-43.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 2.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $-43.5M | ||
| Q3 25 | $633.2K | $-47.0M | ||
| Q2 25 | $-1.4M | $-39.6M | ||
| Q1 25 | $-3.3M | $-40.7M | ||
| Q4 24 | $9.1M | $42.0M | ||
| Q3 24 | $4.7M | $-14.5M | ||
| Q2 24 | $-6.5M | $-7.3M | ||
| Q1 24 | $-637.0K | $-6.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | $9.0M | $41.7M | ||
| Q3 24 | $4.6M | $-14.6M | ||
| Q2 24 | $-6.7M | $-7.3M | ||
| Q1 24 | $-741.4K | $-6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | 49.7% | 48.2% | ||
| Q3 24 | 18.1% | -706.3% | ||
| Q2 24 | -19.0% | -1463.4% | ||
| Q1 24 | -2.5% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | 0.2% | 0.3% | ||
| Q3 24 | 0.3% | 6.8% | ||
| Q2 24 | 0.7% | 7.6% | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 2.01× | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | -17.92× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.30× | — | ||
| Q1 24 | -0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMO
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
